A new non-hormonal antifertility drug DL-204: I. Effects on testes and accessory glands of reproduction in male rats.

Abstract:

:The effect of DL-204, 2-(3-ethoxyphenyl)-5,6-dihydro-5-triazole (5,1a)-isoquinoline, a non-hormonal post-implantational anti-fertility drug, on tissue weights, nucleic acids and total protein concentrations in the testes, ventral prostate and seminal vesicles were evaluated in immature and sexually mature rats, while changes in DNA synthesis were studied only in the immature rats. Treatment of 21-day-old rats at doses of 5mg and 10mg/kg bw once daily for 15 days had no effect on body weight but reduced the weights of testes and accessory glands of reproduction. The concentration of DNA increased while RNA and protein decreased significantly. Treatment of adult rats with DL-204 at a dose of 10mg/kg bw had no effect on body and testes weights but reduced ventral prostate and seminal vesicle weights. The concentration of RNA and protein decreased significantly, while DNA concentration was not altered. DL-204 treatment resulted in drastic decrease of RNA/DNA ratio, reflecting ribosomal loss and cytoplasmic shrinkage. The effects observed after DL-204 treatment are comparable to post-castration changes. DL-204 may be acting on testes and accessory reproductive organs by blocking androgen biosynthesis and/or by antagonizing the action of androgens. It may be acting directly on the normal function of the hypothalamo-pituitary-gonadal axis.

journal_name

Contraception

journal_title

Contraception

authors

Prasad RS,Vijayan E

doi

10.1016/0010-7824(87)90008-4

subject

Has Abstract

pub_date

1987-11-01 00:00:00

pages

557-66

issue

5

eissn

0010-7824

issn

1879-0518

pii

0010-7824(87)90008-4

journal_volume

36

pub_type

杂志文章
  • The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods.

    abstract::A placebo-controlled, double-blind study was carried out to assess the direct hormonal effects of combined and progestogen-only oral contraceptives on well-being and sexuality of women in two contrasting cultures. One-hundred-fifty women, who had been sterilised or whose partners had been vasectomised, were recruited ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/0010-7824(95)00226-x

    authors: Graham CA,Ramos R,Bancroft J,Maglaya C,Farley TM

    更新日期:1995-12-01 00:00:00

  • Safety of intrauterine devices among women with HIV: a systematic review.

    abstract:BACKGROUND:Use of highly effective contraception among women living with HIV is critical to prevent unintended pregnancy and subsequent risk of maternal complications and perinatal HIV transmission. However, it is not known whether use of intrauterine devices (IUDs) among women with advanced HIV disease poses an increa...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.06.011

    authors: Tepper NK,Curtis KM,Nanda K,Jamieson DJ

    更新日期:2016-12-01 00:00:00

  • Effects of intrauterine contraception on the vaginal microbiota.

    abstract:OBJECTIVES:There have been conflicting reports of altered vaginal microbiota and infection susceptibility associated with contraception use. The objectives of this study were to determine if intrauterine contraception altered the vaginal microbiota and to compare the effects of a copper intrauterine device (Cu-IUD) and...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.05.017

    authors: Bassis CM,Allsworth JE,Wahl HN,Sack DE,Young VB,Bell JD

    更新日期:2017-09-01 00:00:00

  • Provision of medical abortion by midlevel healthcare providers in Kyrgyzstan: testing an intervention to expand safe abortion services to underserved rural and periurban areas.

    abstract:OBJECTIVE:To demonstrate the feasibility and safety of training midlevel healthcare providers (midwives and family nurses) to provide medical abortion and postabortion contraception in underserved areas in Kyrgyzstan. STUDY DESIGN:This was an implementation study at four referral facilities and 28 Felsher Obstetric Po...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.11.002

    authors: Johnson BR Jr,Maksutova E,Boobekova A,Davletova A,Kazakbaeva C,Kondrateva Y,Landoulsi S,Lazdane G,Monolbaev K,Seuc Jo AH

    更新日期:2018-02-01 00:00:00

  • Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database.

    abstract:OBJECTIVE:To describe clinical outcomes of etonogestrel implant patients with migration to the vasculature, chest wall and other distant body sites spontaneously reported to the US Food and Drug Administration Adverse Event Reporting System (FAERS) database. STUDY DESIGN:We performed a standardized Medical Dictionary ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.08.009

    authors: Kang S,Niak A,Gada N,Brinker A,Jones SC

    更新日期:2017-12-01 00:00:00

  • Use of erythromycin for nonsurgical female sterilization in West Bengal, India: a study of 790 cases.

    abstract:OBJECTIVE:Determine if erythromycin is an effective agent for achieving occlusion of the Fallopian tube for nonsurgical female sterilization. METHODS:Two studies of 100 healthy volunteers requesting sterilization were planned, one in Julpia Andhermanik and the other in Kolkata (Calcutta). A readily available marketed ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2003.07.005

    authors: Bairagy NR,Mullick BC

    更新日期:2004-01-01 00:00:00

  • Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank,

    abstract::A 1-year longitudinal multicenter study was undertaken to monitor the effects on lipid metabolism of two once-a-month injectable contraceptive preparations, Mesigyna (50 mg norethisterone enanthate and 5 mg estradiol valerate and Cyclofem (25 mg medroxyprogesterone acetate and 5 mg estradiol cypionate). A total of 357...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors:

    更新日期:1997-10-01 00:00:00

  • Emergency contraception in Jordan: Assessing retail pharmacists' awareness, opinions, and perceptions of need.

    abstract:OBJECTIVES:Jordan has a robust contraceptive method mix in both the public and private sectors and oral contraceptive pills and the copper-T intrauterine device are widely available. However, Jordan remains one of only a few countries in the world without a registered dedicated product for emergency contraception (EC)....

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2019.10.002

    authors: El-Mowafi IM,Foster AM

    更新日期:2020-04-01 00:00:00

  • Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.

    abstract:OBJECTIVE:Pharmacokinetics of norethindrone in combination oral contraceptive regimen are well described among HIV+ women treated with ritonavir-boosted protease inhibitor therapies; however, such characterization is lacking in women using progestin-only contraception. Our objective is to characterize pharmacokinetics ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.08.009

    authors: DuBois BN,Atrio J,Stanczyk FZ,Cherala G

    更新日期:2015-01-01 00:00:00

  • Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.

    abstract:OBJECTIVES:To measure the 24-month impact on continuation, unintended pregnancy and satisfaction of trying long-acting reversible contraception (LARC) in a population seeking short-acting reversible contraception (SARC). STUDY DESIGN:We enrolled 916 women aged 18-29 who were seeking pills or injectables in a partially...

    journal_title:Contraception

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.contraception.2018.02.001

    authors: Hubacher D,Spector H,Monteith C,Chen PL

    更新日期:2018-06-01 00:00:00

  • Postabortal contraception with norethisterone enanthate injections.

    abstract::Intramuscular injection of 200 mg norethisterone enanthate (NET-EN) was given to five women on the day of first trimester abortion. The injection was repeated twice at eight-week intervals, and thereafter at twelve-week intervals for one year. Plasma samples were collected for FSH, LH/hCG, estradiol, progesterone and ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(83)90020-3

    authors: Lähteenmäki P,Toivonen J,Lähteenmäki PL

    更新日期:1983-06-01 00:00:00

  • Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.

    abstract::Combination oral contraceptive (COC) users have reduced risks of ovarian and endometrial cancer, but COCs have not reduced breast cancer risk. We have previously argued that a hormonal contraceptive with substantially lower doses of sex-steroids should reduce breast cancer risk by decreasing the breast epithelial cell...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(93)90095-o

    authors: Spicer DV,Pike MC,Pike A,Rude R,Shoupe D,Richardson J

    更新日期:1993-05-01 00:00:00

  • Comparative multicentre trial of three IUDs inserted immediately following delivery of the placenta.

    abstract::A multinational comparative trial of three IUDs (Copper 7, Lippes loop size D and the Postpartum T) randomly inserted immediately following delivery of the placenta was conducted in six centres. A total of 841 women entered the study. As the predetermined termination indices for expulsions were exceeded at six months ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(80)90112-2

    authors:

    更新日期:1980-07-01 00:00:00

  • Termination of early pregnancy (menstrual induction) with 16-phenoxy-omega-tetranor PGE2 methylsulfonylamide.

    abstract::The efficacy and side effects of a new synthetic compound, 16-phenoxy-W-17, 18, 19, 20-tetranor prostaglandin E2 methylsulfonylamide, for menstrual induction. The study was conducted in an outpatient clinic in 240 patients with a delay in menstruation of 6-14 days. In 206 patients (86%) the immunologic pregnancy tes...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(77)90049-x

    authors: Karim SM,Rao B,Ratnam SS,Prasad RN,Wong YM,Ilancheran A

    更新日期:1977-10-01 00:00:00

  • A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64-70 and 71-77 days of gestation: A retrospective chart review.

    abstract:OBJECTIVE:To compare the effectiveness of outpatient medical abortion with mifepristone 200 mg and two misoprostol 800 mcg doses at 64-70 and 71-77 days of gestation. STUDY DESIGN:We conducted a retrospective chart review of medical abortion outcomes among clients with 64-77 day gestations at a Mexico City public clin...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.05.012

    authors: Dzuba IG,Castillo PW,Bousiéguez M,Lugo Hernández EM,Castañeda Vivar JJ,Sanhueza Smith P

    更新日期:2020-08-01 00:00:00

  • Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.

    abstract::The objective of this double-blind, placebo-controlled study was to evaluate the effect of mefenamic acid and placebo on controlling irregular uterine bleeding in depot-medroxyprogesterone acetate (DMPA) users. A total of 48 DMPA users attending the Family Planning Clinic, Chulalongkorn Hospital were studied, all had ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2004.04.003

    authors: Tantiwattanakul P,Taneepanichskul S

    更新日期:2004-10-01 00:00:00

  • Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.

    abstract:PURPOSE:Positive effects on premenstrual symptoms have been observed with low-dose oral contraceptives. Drospirenone is a synthetic progestogen with antiandrogenic and antimineralocorticoid effects. This open-label, multicenter study evaluated the effects of a combination of ethinylestradiol 30 microg and drospirenone ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.contraception.2005.10.016

    authors: Borges LE,Andrade RP,Aldrighi JM,Guazelli C,Yazlle ME,Isaia CF,Petracco A,Peixoto FC,Camargos AF

    更新日期:2006-12-01 00:00:00

  • Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials.

    abstract::Changes in body weight and the incidence of estrogen-related side effects with low-dose oral contraceptives (OCs) containing 20 microg ethinyl estradiol (EE) have not been demonstrated in placebo-controlled trials. Two placebo-controlled, randomized trials demonstrated the efficacy of a low-dose OC for the treatment o...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(01)00208-6

    authors: Coney P,Washenik K,Langley RG,DiGiovanna JJ,Harrison DD

    更新日期:2001-06-01 00:00:00

  • Medications to ease intrauterine device insertion: a systematic review.

    abstract:BACKGROUND:Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women. OBJECTIVE:This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adj...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/j.contraception.2016.06.014

    authors: Zapata LB,Jatlaoui TC,Marchbanks PA,Curtis KM

    更新日期:2016-12-01 00:00:00

  • Associations of mental illness and substance use disorders with prescription contraception use among women veterans.

    abstract:OBJECTIVE:To investigate whether mental illness and substance use disorder (SUD) are associated with having a prescription contraceptive method among women veterans. STUDY DESIGN:We conducted a retrospective analysis of National Veterans Administration (VA) administrative and clinical data for women veterans aged 18-4...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.02.028

    authors: Callegari LS,Zhao X,Nelson KM,Lehavot K,Bradley KA,Borrero S

    更新日期:2014-07-01 00:00:00

  • Use of multiple clips for tubal occlusion in interval laparoscopic sterilization: circumstances and consequences.

    abstract::The use of multiple clips for the occlusion of the Fallopian tubes has been reported in interval laparoscopic sterilization, but the circumstances leading to the performance of the multiple-clip procedure and its effects on safety and efficacy have not been carefully studied. A data set from international multi-center...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/0010-7824(94)90058-2

    authors: Chi IC

    更新日期:1994-11-01 00:00:00

  • Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.

    abstract:BACKGROUND:This study was conducted to evaluate long-term safety of quinacrine pellets for nonsurgical sterilization among women in Vietnam. STUDY DESIGN:Observational cohort study of 2735 women who had quinacrine insertions between 1989 and 1993 compared to 1623 women who received an intrauterine device (IUD). RESUL...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2008.02.011

    authors: Sokal DC,Hieu do T,Loan ND,Hubacher D,Nanda K,Weiner DH,Vach TH

    更新日期:2008-07-01 00:00:00

  • The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.

    abstract::The efficacy and acceptability of a levonorgestrel-releasing intravaginal ring (IVR) for contraception was assessed in a British cohort studied as part of a multicentre, multinational clinical trial performed under the auspices of the World Health Organisation. One-hundred-and-fifty women took part in the study in two...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(91)90040-m

    authors: Elder MG,Lawson JP,Elstein M,Nuttall ID

    更新日期:1991-02-01 00:00:00

  • Use of hCG stimulation test in women immunized with beta-hCG vaccine.

    abstract::Eleven normally menstruating women, who had earlier been immunized with NII beta-hCG vaccine but had no detectable anti-hCG antibody titres, were selected as controls for the hCG challenge test using 1000/2000 I.U. The test was repeated in five of them after a booster immunization, which raised antibody titres to 18-4...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/0010-7824(91)90035-e

    authors: Shahani SM,Patel KL

    更新日期:1991-10-01 00:00:00

  • Gender, relationship type and contraceptive use at first intercourse.

    abstract:BACKGROUND:Most of the sexually transmitted infection prevention programs fail to attend to the relationship type of individuals at first sexual intercourse and how it influences contraceptive behavior. STUDY DESIGN:A national sample of adolescents (3084 females and 2745 for males) was analyzed to determine the associ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2012.09.030

    authors: Gibbs L

    更新日期:2013-06-01 00:00:00

  • Biological activity in the repopulating rat spermatocyte after the withdrawal of gossypol treatment. VI. Alteration in nuclear factors for interaction with histone gene promoter.

    abstract::This article reports the effects of gossypol at the genomic level in rat spermatogenic cells. After gossypol treatment for various times (8, 12, and 19 weeks), the spermatogonial cells were allowed to rest for 2 to 4 weeks. The function of histone H4 gene promoter (H4GP) in the repopulating pachytene spermatocytes (RP...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/s0010-7824(95)00139-5

    authors: Teng CS,Yang NY,Chen Y

    更新日期:1995-08-01 00:00:00

  • STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.

    abstract::STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9(10)-diene-3-one) is a potent progestin. This compound was 10 times as potent as the standard levonorgestrel as judged by the classic Clauberg-McPhail Assay. The antiprogestational response is significant when STS 557 treatment starts 2 days before progesterone ad...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90140-7

    authors: Oettel M,Kurischko A

    更新日期:1980-01-01 00:00:00

  • Hemostatic changes in women using a monthly injectable contraceptive for one year.

    abstract::The effect of consecutively injecting a one-a-month contraceptive (norethisterone enantate 50 mg with estradiol valerate 5 mg) for one year on haematological parameters was evaluated in 42 Chinese women. The healthy volunteers were randomly allocated to either the treatment group (22) or a control group (20). Blood sa...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(90)90052-w

    authors: Meng YX,Jiang HY,Chen AJ,Lu FY,Yang H,Zhang MY,Shen KY,Sun DL,Shao QX,Fotherby K

    更新日期:1990-10-01 00:00:00

  • A single-blinded randomized controlled trial evaluating pain and opioid use after dilator placement for second-trimester abortion.

    abstract:OBJECTIVES:To compare pain levels and medication needs after placement of laminaria vs Dilapan-S, and after dilation and evacuation (D&E). STUDY DESIGN:We conducted a single-blinded randomized control trial of patients undergoing D&E at 15 0/7 to 23 6/7 weeks gestation, randomizing to cervical preparation with laminar...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.11.014

    authors: Liu SM,Flink-Bochacki R

    更新日期:2020-12-04 00:00:00

  • Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.

    abstract::This prospective, open-label, randomized trial of healthy adult women up to 9 weeks pregnant compared mifepristone 200 mg followed 2 days later with misoprostol 400 microg orally versus misoprostol 800 microg vaginally. The study was interrupted after the oral misoprostol group experienced a higher than expected failu...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0010-7824(02)00366-9

    authors: Schaff EA,Fielding SL,Westhoff C

    更新日期:2002-10-01 00:00:00